What is Lamda Biotech?
Operating as a critical partner to the global life science research community, Lamda Biotech specializes in the invention, development, and commercialization of high-quality laboratory technologies. By prioritizing value-priced solutions and expert technical support, the company has carved out a distinct niche as a research support partner. Their business model is specifically engineered to address the budgetary constraints of modern laboratories, offering tiered pricing structures that cater to both emerging start-up research facilities and high-volume institutional buyers. This strategic focus on cost-efficiency without compromising scientific integrity has allowed Lamda Biotech to maintain a robust market position, effectively bridging the gap between complex research requirements and accessible, high-performance supply chains.
How much funding has Lamda Biotech raised?
Lamda Biotech has raised a total of $37K across 1 funding round:
Debt
$37K
Debt (2021): $37K with participation from PPP
Key Investors in Lamda Biotech
PPP
Public-Private Partnership
What's next for Lamda Biotech?
With the infusion of $37K, Lamda Biotech is poised to transition into a more aggressive growth phase. The strategic roadmap likely involves expanding its R&D capabilities to introduce next-generation diagnostic and experimental tools, while simultaneously scaling its distribution network to capture a larger share of the international life science market. By leveraging this capital, the company aims to solidify its infrastructure, enhance its technical support ecosystem, and further optimize its supply chain to meet the increasing demand for reliable, cost-effective research materials. As the firm matures, the focus will shift toward sustaining long-term profitability and reinforcing its reputation as an indispensable asset to the scientific community, ensuring that researchers can maximize their own funding through Lamda's value-driven product offerings.
See full Lamda Biotech company page
